China Isotope & Radiation Corporation (HKG:1763)
22.00
+0.06 (0.27%)
Feb 11, 2026, 11:39 AM HKT
China Isotope & Radiation Revenue
China Isotope & Radiation had revenue of 2.86B CNY in the half year ending June 30, 2025, with 4.32% growth. This brings the company's revenue in the last twelve months to 7.62B, up 13.67% year-over-year. In the year 2024, China Isotope & Radiation had annual revenue of 7.57B with 14.16% growth.
Revenue (ttm)
7.62B CNY
Revenue Growth
+13.67%
P/S Ratio
0.84
Revenue / Employee
2.27M CNY
Employees
3,361
Market Cap
7.02B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.57B | 939.76M | 14.16% |
| Dec 31, 2023 | 6.63B | 481.44M | 7.82% |
| Dec 31, 2022 | 6.15B | 1.01B | 19.63% |
| Dec 31, 2021 | 5.14B | 869.51M | 20.34% |
| Dec 31, 2020 | 4.27B | 285.28M | 7.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AK Medical Holdings | 1.52B |
| LifeTech Scientific | 1.45B |
| Beijing Chunlizhengda Medical Instruments | 1.15B |
| Zylox-Tonbridge Medical Technology | 984.51M |
| MicroPort NeuroScientific | 807.00M |
| Peijia Medical | 731.61M |
| Acotec Scientific Holdings | 649.64M |
| LEPU ScienTech Medical Technology (Shanghai) | 605.14M |